Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,901 | 1,588 | 12,500 | 5,000 | 0 |
| Cost of Goods | 1,076 | N/A | N/A | N/A | N/A |
| Gross Profit | 825 | 1,170 | 12,500 | 5,000 | N/A |
| Operating Expenses | 45,036 | 40,051 | 31,387 | 21,857 | 16,931 |
| Operating Income | -44,135 | -38,463 | -18,887 | -16,857 | -16,931 |
| Other Income | 2,647 | 2,569 | 2,187 | 2,445 | 2,312 |
| Pre-tax Income | -41,488 | -35,894 | -16,700 | -14,412 | -14,619 |
| Income Tax | N/A | 2 | N/A | 500 | N/A |
| Net Income Continuous | -41,488 | -35,896 | -16,700 | -14,912 | -14,619 |
| Net Income | $-41,488 | $-35,896 | $-16,700 | $-14,912 | $-14,619 |
| EPS Basic Total Ops | -1.32 | -1.20 | -0.59 | -0.53 | -0.53 |
| EPS Basic Continuous Ops | -1.32 | -1.20 | -0.59 | -0.53 | -0.53 |
| EPS Diluted Total Ops | -1.32 | -1.20 | -0.59 | -0.53 | -0.53 |
| EPS Diluted Continuous Ops | -1.32 | -1.20 | -0.59 | -0.53 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -1.32 | -1.16 | -0.59 | -0.53 | -0.53 |
| EBITDA(a) | $-44,024 | $-38,356 | $-16,740 | $-18,860 | $-16,895 |